The authors reply

  • Jordan A. Woolum
  • , Alexander H. Flannery

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e435-e436
JournalCritical Care Medicine
Volume47
Issue number5
DOIs
StatePublished - May 1 2019

Bibliographical note

Funding Information:
Drs. McCurdy, Khanna, and Busse received funding from La Jolla Pharmaceuticals. Drs. McCurdy and Khanna disclosed off-label product use of angiotensin II in resuscitation.

Funding

Drs. McCurdy, Khanna, and Busse received funding from La Jolla Pharmaceuticals. Drs. McCurdy and Khanna disclosed off-label product use of angiotensin II in resuscitation.

Funders
La Jolla Pharmaceuticals

    ASJC Scopus subject areas

    • Critical Care and Intensive Care Medicine

    Cite this